News
Investment
Lifestyle
Videos
Search for:
Search
More
Contact
Features
News
Home
Biotech
Investment
Diagnostics
Agetech
Supplements
Innovation
AI/Digital
Economy
Investment
More power to you – why energy could be the key to longevity
Investment
Meet the investor: Sergey Young
Investment
Longevity investment bulletin: PocDoc, AbbVie, Athersys and more
Longevity investment bulletin, featuring PocDoc, AbbVie, Athersys, Remedium Bio, Biophytis, Mitrix Bio, Biophysical Tx and Sergey Young.
Investment
Biophysical Therapeutics opens crowdfunding investment raise
Investment
Longevity investment bulletin: Vaxxinity, Aviceda, MyMD and more
Investment
New data suggest investigational osteoarthritis drug may have promising senotherapeutic effect
Investment
TruDiagnostic and NADMED partner on new NAD blood diagnostic
Investment
Longevity investment bulletin: Celmatix, BlueRock, TruDiagnostic and more
Investment
Retro: A longevity biotech triple-threat?
Investment
Cyclarity: When bad guy cells have a change of heart
Investment
Stressed tissue and cellular burn-out? Enter the Mitochondrial Cycle
Investment
Cambrian Bio reveals new pipeline company with focus on AMPK activation
Investment
Longevity investment bulletin: Remedium Bio, GenSight Biologics, SomaLogic and more
Investment
First longevity clinical study design fetches FDA approval
Investment
Longevity investment bulletin: ChromaDex, Nightingale Health, Capsida and more
Investment
OpenAI CEO invested $180 million in longevity company Retro Bio
Investment
Meet the founder: Yuri Deigin
Investment
MitoRx announces Scientific Advisory Board as its ASA enters final few weeks.
Investment
Plant-derived osteoarthritis drug ready for further Phase 2 trials
Investment
Longevity investment bulletin: Assured Allies, Fountain Life, Form Bio and more
Investment
Longevity company Biophysical Therapeutics emerges from stealth
Investment
Longevity investment bulletin: Longeveron, EVERMIND, Longevity Labs and more
Investment
How the longevity industry can deliver lives that are healthier – physically and mentally
Investment
Leonhardt Ventures and Lionheart Health file patent for bioelectric control of antiaging protein expression
Investment
Longevity investment bulletin: Five Alarm Bio, Capsida, MyMD and more
Investment
Causeway Therapeutics secures £8.75 million for Phase 2 trial of tendinopathy therapy
Investment
Gameto licenses Wyss technology for growing human ovaries
Investment
Longevity investment bulletin: Impact funds, Lineage Cell Therapeutics and Maximon
Investment
Longevity investment bulletin: Athersys, Maze, TreeFrog and more
Investment
Life Biosciences appoints new Chief Scientific Officer
Investment
Morphoceuticals raises $8m to advance electroceutical approach to regenerative medicine
Investment
LongeVC joins psychedelics startup Freedom Biosciences’ funding round
Investment
Load More